Andreea M. Bujor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andreea M. Bujor has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Maria Trojanowska
Boston University
17 shared publications - Justin K. Lui
The Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine Boston Massachusetts
7 shared publications - Marcin A. Trojanowski
Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, USA
7 shared publications - Robert Lafyatis
Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, USA
6 shared publications - Elizabeth S. Klings
Department of Medicine Boston University Chobanian & Avedisian School of Medicine Boston Massachusetts USA
5 shared publications - Michael P. LaValley
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
5 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (11)
The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity
T cells in patients with chronic autoimmunity show features of dysfunction. However, the functionally defined T cell subsets that are affected by these changes remain poorly characterized. Here, we sought to reveal aberrations in the composition, phenotype, and function of canonical T cell subsets in the blood of systemic sclerosis (SSc) patients compared with healthy subjects and systemic lupus erythematosus (SLE) patients. Therefore, we developed a novel multidimensional flow-cytometry panel to simultaneously detect lineage-defining transcription factors, co-inhibitory receptors and other functional markers to characterize T cell subsets without in vitro restimulation. We compared T cell landscapes in SSc and SLE patients, and healthy subjects, using opt-SNE (optimized t-distributed stochastic neighbor embedding) and PhenoGraph algorithms. The data show altered distribution and aberrant functional states of transcription factor–defined T cell subsets in patients with autoimmunity, with shared and unique features between diseases and their subtypes. Strikingly, SSc and SLE patients showed deficiencies in subsets of CD8+ and CD4−CD8− T cells that expressed T-bet, which is critical for IFN-γ–dependent type 1 immunity. Moreover, TIGIT+Foxp3+ regulatory T cells, which suppress T helper 1 responses, were increased in diffuse cutaneous SSc and SLE patients. Functionally, T cells from SSc patients produced less IFN-γ, a cytokine that suppresses profibrotic gene expression in fibroblasts, as we demonstrate by transcriptomic analysis. Our study supports a model in which IFN-γ opposes canonical fibrotic gene programs in fibroblasts, and deficiencies in the IFN-γ–producing T cell compartment in SSc patients therefore may contribute to chronic fibrosis development. Aberrant T cell subsets in SSc and SLE represent targets for corrective immunotherapy.
- 2 November 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (11)
Open AccessThe altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity
T cells in patients with chronic autoimmunity show features of dysfunction. However, the functionally defined T cell subsets that are affected by these changes remain poorly characterized. Here, we sought to reveal aberrations in the composition, phenotype, and function of canonical T cell subsets in the blood of systemic sclerosis (SSc) patients compared with healthy subjects and systemic lupus erythematosus (SLE) patients. Therefore, we developed a novel multidimensional flow-cytometry panel to simultaneously detect lineage-defining transcription factors, co-inhibitory receptors and other functional markers to characterize T cell subsets without in vitro restimulation. We compared T cell landscapes in SSc and SLE patients, and healthy subjects, using opt-SNE (optimized t-distributed stochastic neighbor embedding) and PhenoGraph algorithms. The data show altered distribution and aberrant functional states of transcription factor–defined T cell subsets in patients with autoimmunity, with shared and unique features between diseases and their subtypes. Strikingly, SSc and SLE patients showed deficiencies in subsets of CD8+ and CD4−CD8− T cells that expressed T-bet, which is critical for IFN-γ–dependent type 1 immunity. Moreover, TIGIT+Foxp3+ regulatory T cells, which suppress T helper 1 responses, were increased in diffuse cutaneous SSc and SLE patients. Functionally, T cells from SSc patients produced less IFN-γ, a cytokine that suppresses profibrotic gene expression in fibroblasts, as we demonstrate by transcriptomic analysis. Our study supports a model in which IFN-γ opposes canonical fibrotic gene programs in fibroblasts, and deficiencies in the IFN-γ–producing T cell compartment in SSc patients therefore may contribute to chronic fibrosis development. Aberrant T cell subsets in SSc and SLE represent targets for corrective immunotherapy.
- 1 September 2026
- Published by Wiley in Arthritis & Rheumatology
Down‐Regulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis Via a Galectin‐3/ mTOR Dependent Pathway
Objective: To determine whether down‐regulation of the transcription factor Fli1 in myeloid cells, previously implicated in profibrotic programming in systemic sclerosis (SSc), promotes cardiac fibrosis and dysfunction in SSc and to define the underlying mechanisms. Methods: Immunohistochemistry for Fli1 and galectin‐3 (Gal‐3) was performed on SSc and control cardiac tissue (n = 6–7). Circulating monocytes were analyzed for Gal‐3 protein and messenger RNA (mRNA) levels. Cardiac fibrosis and function were evaluated in young and aged myeloid‐specific Fli1 knockout mice (Lyz2Cre/Fli1 fl/fl ), by collagen staining and echocardiography. Co‐culture experiments using human macrophages and primary human cardiac fibroblasts, Fli1 and Gal‐3 knockdown, recombinant human Gal‐3, and rapamycin were used to dissect mTORC1‐dependent profibrotic signaling. Results: Fli1 expression was reduced (~6‐fold, P = 0.0103), whereas Gal‐3 was increased (~4‐fold, P = 0.0031) in SSc myocardium compared with control. SSc monocytes expressed elevated Gal‐3 protein (~2‐fold, P = 0.0235) and mRNA levels (~1.7‐fold, P = 0.0448). Lyz2Cre /Fli1 fl/fl mice had increased myocardial collagen and diastolic dysfunction with elevated mitral E/e′ (23.79 ± 8.11 vs 18.76 ± 8.09, P = 0.04) but preserved systolic function; in aged mice, fibrosis was further increased, and systolic function was also impaired (left ventricular ejection fraction 47.41 ± 5.07 vs 66.15 ± 11.49, P = 0.0006). Mechanistically, Fli1 loss derepressed the LGALS3 promoter, increasing Gal‐3 in macrophages and activating mTORC1 in cardiac fibroblasts, and Gal‐3 or mTORC1 inhibition blunted fibroblast activation. Conclusion: Fli1 deficiency in myeloid cells drives Gal‐3–dependent activation of mTORC1 in cardiac fibroblasts, promoting cardiac fibrosis and dysfunction in SSc. These findings identify a myeloid Fli1–Gal‐3–mTORC1 axis as a central pathway in SSc‐associated cardiac fibrosis and a potential therapeutic target. image
- 1 September 2026
- Published by Wiley in Arthritis & Rheumatology
Down‐Regulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis Via a Galectin‐3/ mTOR Dependent Pathway
Objective: To determine whether down‐regulation of the transcription factor Fli1 in myeloid cells, previously implicated in profibrotic programming in systemic sclerosis (SSc), promotes cardiac fibrosis and dysfunction in SSc and to define the underlying mechanisms. Methods: Immunohistochemistry for Fli1 and galectin‐3 (Gal‐3) was performed on SSc and control cardiac tissue (n = 6–7). Circulating monocytes were analyzed for Gal‐3 protein and messenger RNA (mRNA) levels. Cardiac fibrosis and function were evaluated in young and aged myeloid‐specific Fli1 knockout mice (Lyz2Cre/Fli1 fl/fl ), by collagen staining and echocardiography. Co‐culture experiments using human macrophages and primary human cardiac fibroblasts, Fli1 and Gal‐3 knockdown, recombinant human Gal‐3, and rapamycin were used to dissect mTORC1‐dependent profibrotic signaling. Results: Fli1 expression was reduced (~6‐fold, P = 0.0103), whereas Gal‐3 was increased (~4‐fold, P = 0.0031) in SSc myocardium compared with control. SSc monocytes expressed elevated Gal‐3 protein (~2‐fold, P = 0.0235) and mRNA levels (~1.7‐fold, P = 0.0448). Lyz2Cre /Fli1 fl/fl mice had increased myocardial collagen and diastolic dysfunction with elevated mitral E/e′ (23.79 ± 8.11 vs 18.76 ± 8.09, P = 0.04) but preserved systolic function; in aged mice, fibrosis was further increased, and systolic function was also impaired (left ventricular ejection fraction 47.41 ± 5.07 vs 66.15 ± 11.49, P = 0.0006). Mechanistically, Fli1 loss derepressed the LGALS3 promoter, increasing Gal‐3 in macrophages and activating mTORC1 in cardiac fibroblasts, and Gal‐3 or mTORC1 inhibition blunted fibroblast activation. Conclusion: Fli1 deficiency in myeloid cells drives Gal‐3–dependent activation of mTORC1 in cardiac fibroblasts, promoting cardiac fibrosis and dysfunction in SSc. These findings identify a myeloid Fli1–Gal‐3–mTORC1 axis as a central pathway in SSc‐associated cardiac fibrosis and a potential therapeutic target. image
- 24 May 2026
- Published by Wiley in Arthritis & Rheumatology
Cytokine Profiling of Systemic Sclerosis–Related Pulmonary Hypertension
Objective: The study objective was to use multiplex immunoassays to create a cytokine profile specific for systemic sclerosis–related pulmonary hypertension (SSc‐PH) by assessing circulating plasma of patients with SSc. Methods: This was an observational single‐center study using plasma samples collected from 106 patients with SSc (24 with SSc‐PH by right heart catheterization) in which we measured 48 circulating cytokines using multiplex immunoassays. We applied a random forest approach to create a full 48‐cytokine model and a subsequent collapsed model based on variable importance by the mean decrease in the Gini index. The model was internally validated using a train‐test split of the data from which we generated receiver operating characteristic curves and calculated sensitivity, specificity, and accuracy. Results: The 48‐cytokine model achieved an area under the curve of 0.82 (95% confidence interval [CI] 0.62–1.00). Monokine induced by gamma interferon was the most important cytokine associated with SSc‐PH by Gini index. Using the elbow method, a collapsed model was achieved using six cytokines (monokine induced by gamma interferon, interleukin‐8, macrophage inflammatory protein‐1β, interleukin‐15, interleukin‐7, and macrophage‐derived chemokine) that yielded an area under the curve of 0.83 (95% CI 0.72–1.00) with a sensitivity, specificity, and accuracy of 0.14 (95% CI 0.00–0.58), 0.96 (95% CI 0.80–1.00), and 0.78 (95% CI 0.60–0.91), respectively. Conclusion: Using a single‐center SSc cohort that reflects real‐world heterogeneity, we generated a highly specific cytokine profile for SSc‐PH through a random forest approach. Future work will need to externally validate the cytokine profile through prospective cohorts.
- 24 May 2026
- Published by Wiley in Arthritis & Rheumatology
Cytokine Profiling of Systemic Sclerosis–Related Pulmonary Hypertension
Objective: The study objective was to use multiplex immunoassays to create a cytokine profile specific for systemic sclerosis–related pulmonary hypertension (SSc‐PH) by assessing circulating plasma of patients with SSc. Methods: This was an observational single‐center study using plasma samples collected from 106 patients with SSc (24 with SSc‐PH by right heart catheterization) in which we measured 48 circulating cytokines using multiplex immunoassays. We applied a random forest approach to create a full 48‐cytokine model and a subsequent collapsed model based on variable importance by the mean decrease in the Gini index. The model was internally validated using a train‐test split of the data from which we generated receiver operating characteristic curves and calculated sensitivity, specificity, and accuracy. Results: The 48‐cytokine model achieved an area under the curve of 0.82 (95% confidence interval [CI] 0.62–1.00). Monokine induced by gamma interferon was the most important cytokine associated with SSc‐PH by Gini index. Using the elbow method, a collapsed model was achieved using six cytokines (monokine induced by gamma interferon, interleukin‐8, macrophage inflammatory protein‐1β, interleukin‐15, interleukin‐7, and macrophage‐derived chemokine) that yielded an area under the curve of 0.83 (95% CI 0.72–1.00) with a sensitivity, specificity, and accuracy of 0.14 (95% CI 0.00–0.58), 0.96 (95% CI 0.80–1.00), and 0.78 (95% CI 0.60–0.91), respectively. Conclusion: Using a single‐center SSc cohort that reflects real‐world heterogeneity, we generated a highly specific cytokine profile for SSc‐PH through a random forest approach. Future work will need to externally validate the cytokine profile through prospective cohorts.
- Open Access
- 5 May 2026
- Published by Wiley in Arthritis Care & Research
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
Objective: This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods: Data from adults with early SSc (P < 0.001). RWA of clinical variables identified modified Rodnan skin score (mRSS) and New York Heart Association (NYHA) functional class as most influential for both global assessments. After including PROs, PtGA was most influenced by measures of pain, skin symptoms, and physical function. Discordance occurred in 53% of patients (35% PtGA worse, 18% PhGA worse). Worse PtGA was associated with higher overall pain and discomfort. Worse PhGA was associated with higher mRSS, worse NYHA class, higher pain interference, and lower diffusing capacity of the lung. Conclusion: Discordance between PtGA and PhGA occurs commonly, highlighting the need for comprehensive symptom management and measurement of disease burden in this complex disease. In SSc, differences in PtGA and PhGA reflect dissimilar weighting of data elements.
- 5 May 2026
- Published by Wiley in Arthritis Care & Research
Open AccessDiscordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
Objective: This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods: Data from adults with early SSc (P < 0.001). RWA of clinical variables identified modified Rodnan skin score (mRSS) and New York Heart Association (NYHA) functional class as most influential for both global assessments. After including PROs, PtGA was most influenced by measures of pain, skin symptoms, and physical function. Discordance occurred in 53% of patients (35% PtGA worse, 18% PhGA worse). Worse PtGA was associated with higher overall pain and discomfort. Worse PhGA was associated with higher mRSS, worse NYHA class, higher pain interference, and lower diffusing capacity of the lung. Conclusion: Discordance between PtGA and PhGA occurs commonly, highlighting the need for comprehensive symptom management and measurement of disease burden in this complex disease. In SSc, differences in PtGA and PhGA reflect dissimilar weighting of data elements.
- 30 January 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Risk stratifying systemic sclerosis–related pulmonary hypertension by left atrial strain
Objectives: The objective of the study was to explore left atrial (LA) strain, a quantitative index of left ventricular (LV) diastolic function, in risk stratifying patients with SSc-related pulmonary hypertension (SSc-PH). Methods: This was an exploratory, retrospective single-centre study of 124 patients with SSc-PH confirmed on right heart catheterization. We quantified and clustered the three components of LA global longitudinal strain (GLS): (i) reservoir (systole); (ii) conduit (early diastole); and (iii) contractile (late diastole), using echocardiograms closest to timing of right heart catheterization. We applied both the Kaplan–Meier method and a Cox proportional hazards model to determine associations with our primary outcome of all-cause mortality. Results: Using k-means clustering, we divided our cohort into three clusters: Cluster 1 (N = 40), Cluster 2 (N = 34) and Cluster 3 (N = 50). Compared with Cluster 1, Cluster 2 had the lowest median LA conduit strain, and Cluster 3 exhibited the lowest median LA contractile strain. There was a statistically significant difference in survival between clusters (log-rank P = 0.005). Median survival was 122.4 months, 67.9 months and 48.4 months for Cluster 1, Cluster 2 and Cluster 3, respectively. Compared with those in Cluster 1, patients in Cluster 2 and Cluster 3 had adjusted hazard ratios of 1.46 (95% CI: 0.71, 2.97) and 2.57 (95% CI: 1.32, 5.02) for all-cause mortality, respectively. Conclusion: Of the three LA GLS clusters, Cluster 3 had the shortest median survival. LA GLS may provide further risk stratification of patients with SSc-PH.
- 30 January 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Risk stratifying systemic sclerosis–related pulmonary hypertension by left atrial strain
Objectives: The objective of the study was to explore left atrial (LA) strain, a quantitative index of left ventricular (LV) diastolic function, in risk stratifying patients with SSc-related pulmonary hypertension (SSc-PH). Methods: This was an exploratory, retrospective single-centre study of 124 patients with SSc-PH confirmed on right heart catheterization. We quantified and clustered the three components of LA global longitudinal strain (GLS): (i) reservoir (systole); (ii) conduit (early diastole); and (iii) contractile (late diastole), using echocardiograms closest to timing of right heart catheterization. We applied both the Kaplan–Meier method and a Cox proportional hazards model to determine associations with our primary outcome of all-cause mortality. Results: Using k-means clustering, we divided our cohort into three clusters: Cluster 1 (N = 40), Cluster 2 (N = 34) and Cluster 3 (N = 50). Compared with Cluster 1, Cluster 2 had the lowest median LA conduit strain, and Cluster 3 exhibited the lowest median LA contractile strain. There was a statistically significant difference in survival between clusters (log-rank P = 0.005). Median survival was 122.4 months, 67.9 months and 48.4 months for Cluster 1, Cluster 2 and Cluster 3, respectively. Compared with those in Cluster 1, patients in Cluster 2 and Cluster 3 had adjusted hazard ratios of 1.46 (95% CI: 0.71, 2.97) and 2.57 (95% CI: 1.32, 5.02) for all-cause mortality, respectively. Conclusion: Of the three LA GLS clusters, Cluster 3 had the shortest median survival. LA GLS may provide further risk stratification of patients with SSc-PH.
- Open Access
The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.
BACKGROUND T cells in patients with chronic autoimmunity show features of dysfunction and exhaustion. However, the functionally-defined T cell subsets affected by these changes remain poorly characterized. Here, we sought to reveal aberrations in the composition, phenotype and function of canonical T cell subsets in the blood of Systemic Sclerosis (SSc) patients, compared to healthy subjects and Systemic Lupus Erythematosus (SLE) patients. METHODS We developed a novel multidimensional flow-cytometry panel to simultaneously detect lineage-defining transcription factors, co-inhibitory receptors and other functional markers to characterize T cell subsets without in vitro restimulation. We compared T cell landscapes in SSc and SLE patients, and healthy subjects, using Optimized t-SNE and PhenoGraph algorithms. Cytokine production in patient samples was determined using intracellular cytokine staining. Transcriptomic analysis was performed to assess the role of IFN-γ in fibroblasts. RESULTS The data show altered distribution and aberrant functional states of transcription factor-defined T cell subsets in patients with autoimmunity, with shared and unique features between diseases and their subtypes. Strikingly, SSc and SLE patients showed a severe deficiency in subsets of CD8 + and CD4 - CD8 - T cells that expressed T-bet, which is critical for IFN-γ-dependent type 1 immunity, and exhibited features of exhaustion. Moreover, TIGIT + Foxp3 + regulatory T cells, known to suppress Th1 responses, were selectively increased in SSc. Functionally, T cells from SSc patients produced less IFN-γ, a cytokine that suppresses pro-fibrotic gene expression in fibroblasts. CONCLUSION Our study demonstrates that SSc patients have a defective IFN-γ-producing T cell compartment that may lead to reduced anti-fibrotic T cell activity, enabling chronic fibrosis development.
Open AccessThe altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.
BACKGROUND T cells in patients with chronic autoimmunity show features of dysfunction and exhaustion. However, the functionally-defined T cell subsets affected by these changes remain poorly characterized. Here, we sought to reveal aberrations in the composition, phenotype and function of canonical T cell subsets in the blood of Systemic Sclerosis (SSc) patients, compared to healthy subjects and Systemic Lupus Erythematosus (SLE) patients. METHODS We developed a novel multidimensional flow-cytometry panel to simultaneously detect lineage-defining transcription factors, co-inhibitory receptors and other functional markers to characterize T cell subsets without in vitro restimulation. We compared T cell landscapes in SSc and SLE patients, and healthy subjects, using Optimized t-SNE and PhenoGraph algorithms. Cytokine production in patient samples was determined using intracellular cytokine staining. Transcriptomic analysis was performed to assess the role of IFN-γ in fibroblasts. RESULTS The data show altered distribution and aberrant functional states of transcription factor-defined T cell subsets in patients with autoimmunity, with shared and unique features between diseases and their subtypes. Strikingly, SSc and SLE patients showed a severe deficiency in subsets of CD8 + and CD4 - CD8 - T cells that expressed T-bet, which is critical for IFN-γ-dependent type 1 immunity, and exhibited features of exhaustion. Moreover, TIGIT + Foxp3 + regulatory T cells, known to suppress Th1 responses, were selectively increased in SSc. Functionally, T cells from SSc patients produced less IFN-γ, a cytokine that suppresses pro-fibrotic gene expression in fibroblasts. CONCLUSION Our study demonstrates that SSc patients have a defective IFN-γ-producing T cell compartment that may lead to reduced anti-fibrotic T cell activity, enabling chronic fibrosis development.
- 25 July 2025
- Published by BMJ in Journal of Scleroderma and Related Disorders
- Vol. 10 (3) , 472-482
Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways
Objectives: Recent research has highlighted the critical role of monocytes and macrophages in driving both inflammatory and fibrotic processes in systemic sclerosis. This study seeks to elucidate the gene expression profiles of systemic sclerosis monocytes and their potential links to disease complications, with the ultimate goal of uncovering novel therapeutic targets. Methods: A total of 48 systemic sclerosis patients and 15 controls were recruited and monocytes were isolated using CD14+ magnetic beads. Total RNA was extracted and bulk RNA-seq analysis was performed. Differential gene expression followed by unsupervised hierarchical clustering and pathway analysis was conducted, and correlations with clinical features were analyzed. Interferon signature score (IFN6) was calculated using the log transformed values of six genes (IFIT3, IFIT2, MX1, IFIH1, STAT2, and NCF1). Results: We identified four distinct patient subgroups, relative to normal, two with inflammatory and two with non-inflammatory gene profiles. The inflammatory subgroups exhibited high expression of interferon-related genes and included all systemic sclerosis patients with pulmonary hypertension and most with cardiac involvement. In these patients, IFN6 was markedly elevated and showed a significant correlation with global longitudinal strain (GLS; r = −0.5, p = 0.006), a key indicator of cardiac function. Furthermore, pathway analysis identified an enrichment of the Notch signaling pathway among genes whose overexpression correlated with impaired global longitudinal strain. Conclusion: These findings unveil a potential new mechanistic link between interferon activity, Notch signaling, and cardiac complications in systemic sclerosis, offering new insights into disease pathogenesis and potential therapeutic targets.
- 25 July 2025
- Published by BMJ in Journal of Scleroderma and Related Disorders
- Vol. 10 (3) , 472-482
Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways
Objectives: Recent research has highlighted the critical role of monocytes and macrophages in driving both inflammatory and fibrotic processes in systemic sclerosis. This study seeks to elucidate the gene expression profiles of systemic sclerosis monocytes and their potential links to disease complications, with the ultimate goal of uncovering novel therapeutic targets. Methods: A total of 48 systemic sclerosis patients and 15 controls were recruited and monocytes were isolated using CD14+ magnetic beads. Total RNA was extracted and bulk RNA-seq analysis was performed. Differential gene expression followed by unsupervised hierarchical clustering and pathway analysis was conducted, and correlations with clinical features were analyzed. Interferon signature score (IFN6) was calculated using the log transformed values of six genes (IFIT3, IFIT2, MX1, IFIH1, STAT2, and NCF1). Results: We identified four distinct patient subgroups, relative to normal, two with inflammatory and two with non-inflammatory gene profiles. The inflammatory subgroups exhibited high expression of interferon-related genes and included all systemic sclerosis patients with pulmonary hypertension and most with cardiac involvement. In these patients, IFN6 was markedly elevated and showed a significant correlation with global longitudinal strain (GLS; r = −0.5, p = 0.006), a key indicator of cardiac function. Furthermore, pathway analysis identified an enrichment of the Notch signaling pathway among genes whose overexpression correlated with impaired global longitudinal strain. Conclusion: These findings unveil a potential new mechanistic link between interferon activity, Notch signaling, and cardiac complications in systemic sclerosis, offering new insights into disease pathogenesis and potential therapeutic targets.
- Open Access
- 1 April 2025
- Published by SPIE-Intl Soc Optical Eng in Biophotonics Discovery
- Vol. 2 (02) , 025002-14
Structured light imaging mesoscopy: application to skin changes in scleroderma
In part 1 of this two-part publication, structured light imaging mesoscopy (SLIM) was introduced as a new optical technique (part 1 is published in the Journal of Biomedical Optics).1 This noncontact optical method is relatively simple, requiring just a single spatial illumination pattern, no inverse model, and can probe intermediate depths in multilayer media such as skin. Here, we show that SLIM can be applied for the characterization of an autoimmune disease, scleroderma, that affects the scattering properties of the skin,2 particularly in the dermis.3
- 1 April 2025
- Published by SPIE-Intl Soc Optical Eng in Biophotonics Discovery
- Vol. 2 (02) , 025002-14
Open AccessStructured light imaging mesoscopy: application to skin changes in scleroderma
In part 1 of this two-part publication, structured light imaging mesoscopy (SLIM) was introduced as a new optical technique (part 1 is published in the Journal of Biomedical Optics).1 This noncontact optical method is relatively simple, requiring just a single spatial illumination pattern, no inverse model, and can probe intermediate depths in multilayer media such as skin. Here, we show that SLIM can be applied for the characterization of an autoimmune disease, scleroderma, that affects the scattering properties of the skin,2 particularly in the dermis.3
- Top Cited PapersOpen Access
- 27 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis
Progressive lung fibrosis is associated with poorly understood aging-related endothelial cell dysfunction. To gain insight into endothelial cell alterations in lung fibrosis we performed single cell RNA-sequencing of bleomycin-injured lungs from young and aged mice. Analysis reveals activated cell states enriched for hypoxia, glycolysis and YAP/TAZ activity in ACKR1+ venous and TrkB+ capillary endothelial cells. Endothelial cell activation is prevalent in lungs of aged mice and can also be detected in human fibrotic lungs. Longitudinal single cell RNA-sequencing combined with lineage tracing demonstrate that endothelial activation resolves in young mouse lungs but persists in aged ones, indicating a failure of the aged vasculature to return to quiescence. Genes associated with activated lung endothelial cells states in vivo can be induced in vitro by activating YAP/TAZ. YAP/TAZ also cooperate with BDNF, a TrkB ligand that is reduced in fibrotic lungs, to promote capillary morphogenesis. These findings offer insights into aging-related lung endothelial cell dysfunction that may contribute to defective lung injury repair and persistent fibrosis.
- 27 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Top Cited PapersOpen AccessLung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis
Progressive lung fibrosis is associated with poorly understood aging-related endothelial cell dysfunction. To gain insight into endothelial cell alterations in lung fibrosis we performed single cell RNA-sequencing of bleomycin-injured lungs from young and aged mice. Analysis reveals activated cell states enriched for hypoxia, glycolysis and YAP/TAZ activity in ACKR1+ venous and TrkB+ capillary endothelial cells. Endothelial cell activation is prevalent in lungs of aged mice and can also be detected in human fibrotic lungs. Longitudinal single cell RNA-sequencing combined with lineage tracing demonstrate that endothelial activation resolves in young mouse lungs but persists in aged ones, indicating a failure of the aged vasculature to return to quiescence. Genes associated with activated lung endothelial cells states in vivo can be induced in vitro by activating YAP/TAZ. YAP/TAZ also cooperate with BDNF, a TrkB ligand that is reduced in fibrotic lungs, to promote capillary morphogenesis. These findings offer insights into aging-related lung endothelial cell dysfunction that may contribute to defective lung injury repair and persistent fibrosis.
- 13 November 2023
- Published by Springer Nature in Lung
- Vol. 201 (6) , 565-569
A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension
We devised a scoring system to identify patients with systemic sclerosis (SSc) at risk for pulmonary hypertension (PH) and predict all-cause mortality. Using 7 variables obtained via pulmonary function testing, echocardiography, and computed tomographic chest imaging, we applied the score to a retrospective cohort of 117 patients with SSc. There were 60 (51.3%) who were diagnosed with PH by right heart catheterization. Using a scoring threshold ≥ 0, our decision tool predicted PH with a sensitivity, specificity, and accuracy of 0.87 (95% CI 0.75, 0.94), 0.74 (95% CI 0.60, 0.84), and 0.80 (95% CI 0.72, 0.87), respectively. When adjusted for age at PH diagnosis, sex, and receipt of pulmonary arterial vasodilators, each one-point score increase was associated with an adjusted HR of 1.19 (95% CI 1.05, 1.34) for all-cause mortality. With further validation in external cohorts, our simplified clinical decision tool may better streamline earlier detection of PH in SSc.
- 13 November 2023
- Published by Springer Nature in Lung
- Vol. 201 (6) , 565-569
A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension
We devised a scoring system to identify patients with systemic sclerosis (SSc) at risk for pulmonary hypertension (PH) and predict all-cause mortality. Using 7 variables obtained via pulmonary function testing, echocardiography, and computed tomographic chest imaging, we applied the score to a retrospective cohort of 117 patients with SSc. There were 60 (51.3%) who were diagnosed with PH by right heart catheterization. Using a scoring threshold ≥ 0, our decision tool predicted PH with a sensitivity, specificity, and accuracy of 0.87 (95% CI 0.75, 0.94), 0.74 (95% CI 0.60, 0.84), and 0.80 (95% CI 0.72, 0.87), respectively. When adjusted for age at PH diagnosis, sex, and receipt of pulmonary arterial vasodilators, each one-point score increase was associated with an adjusted HR of 1.19 (95% CI 1.05, 1.34) for all-cause mortality. With further validation in external cohorts, our simplified clinical decision tool may better streamline earlier detection of PH in SSc.